EXtension of Tablo TrEatmeNt Duration Registry

Completed

Conditions studied: End Stage Renal Disease (ESRD), End Stage Renal Disease on Dialysis, Acute Kidney Injury

In brief

Observational, retrospective and prospective, multicenter, post-market study of the Tablo Hemodialysis System in hospitalized participants with End-Stage Kidney Disease or Acute Kidney Injury who are prescribed renal replacement therapy \> 12 hours.

Key facts

Study ID

NCT04912050

Run by

Outset Medical

People needed

33

Starts

2021-05-25

Expected to finish

2022-05-31

Last updated by the study team

2022-08-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participant weighs ≥ 34kg.
• Participant is hospitalized and has dialysis dependent End-Stage Kidney Disease or Acute Kidney Injury and is prescribed renal replacement therapy > 12 hours.

You may not qualify if…

• Any documented condition that the Physician feels would prevent the participant from successful inclusion in the study.

Where it is running

• St. Mark's Hospital — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.